³Ô¹ÏÍøÕ¾

Latest oncology News

Palliative Nurses Share Moving Journey
Guild Statement Following ACCC Decision
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
Biomarker may predict immunotherapy response in liver cancer
Karin Holmsten awarded newly established scholarship from the Swedish Society for Urological Oncology
One in three cases of oral cancer are due to smokeless tobacco
Historic reforms for a more competitive economy enter Parliament
Holly shares her story for Breast Cancer Awareness Month
Palliative and Supportive Care Education for Health Professionals – Voluntary Assisted Dying (VAD)
Wind phones help the bereaved deal with death, loss and grief − a clinical social worker explains the vital role of the…
Researching How Virus Affects Aggressive Skin Cancer
Telix’s Phase 3 ZIRCON trial for kidney cancer imaging published in The Lancet Oncology
Mum has ‘miracle’ babies after overcoming ovarian tumour
Race Oncology announces the detail of first phase of board renewal
The benefits of Mindfulness practices during and after treatment
Working to improve vaccine efficacy for children with cancer
Improved survival for breast cancer patients with dose-dense chemotherapy
New guidelines on how to report clinical sequencing data help doctors make decisions about cancer treatment
First look at the Orange Health Service palliative care expansion
NSW latest first look at the Orange Health Service palliative care expansion
How 12,000 Signatures Helped Change Cancer Care Policy
Survivor Joins Cancer Campaign
Immutep reports positive results from trial of combination cancer therapy
Miles Doing What Matters: Cost-of-living relief to support Queenslanders traveling to access healthcare
Study points at novel approach to treat Group 3 medulloblastoma
Türk deplores wave of strikes killing dozens of civilians, including women and children at hospitals: Ukraine
Immutep reports topline results from TACTI-003 Phase 2b trial
Immutep signs exclusive license agreement with Cardiff University for anti-LAG-3 molecules
Femke Hormann awarded prestigious Junior Research Grant from European Hematology Association
US FDA grants rare paediatric disease designation to Race Oncology’s RC220 bisantrene
Race says bisantrene highly active in a mouse model of multiple myeloma
Icon Group’s Proposed Lease Acquisitions Raise Concerns
Newly established Theranostics Trial Center for cancer diagnostics and therapy
Identifying the initial steps in colorectal cancer formation
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
Cancer Research KI network support translational collaboration in molecular mechanisms at Schulte lab
Funding Boost Supports Future Cancer Experts
Starpharma partners with UK investment firm to create Petalion Therapeutics
Imugene’s oncolytic virotherapy CF33 patent granted in China
Myall Lakes seniors’ concerts raise over $3,000 for palliative care
‘Reaching this point in the development of bisantrene is a major milestone and accomplishment’
Sonia Hancock thanked for pivotal role at Mater Research
Amazing Length Of Service
Sting Operation Out Of Gas
Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative breast cancer
Liberals To Deliver $174.8 Million NWRH And Mersey Master Plan